Esteve Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 2.25 Cr
- Company Age 9 Year, 11 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.93 Cr
- Satisfied Charges ₹ 3.25 M
About Esteve Pharma
Esteve Pharma Limited (EPL) is a registered startup operating as a Public Limited Indian Non-Government Company incorporated in India on 15 February 2016 (Nine years 11 days old ). Its registered office is in Dehradun, Uttarakhand, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.25 Cr.
The company currently has active open charges totaling ₹3.93 Cr. The company has closed loans amounting to ₹3.25 M, as per Ministry of Corporate Affairs (MCA) records.
Himanshu Shekhar, Shruti Tiwari, and Sarwavash Kumar serve as directors at the Company.
Company Details
- Location
Dehradun, Uttarakhand, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74900UR2016PLC001918
- Company No.
001918
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
15 Feb 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
What products or services does Esteve Pharma Limited offer?
Esteve Pharma Limited offers a wide range of products and services, including Antibiotic Injection, Piperacillin Tazobactam Injection.
Who are the key members and board of directors at Esteve Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Himanshu Shekhar  | Director | 15-Feb-2016 | Current |
| Shruti Tiwari | Director | 15-Feb-2016 | Current |
| Sarwavash Kumar | Director | 14-Jun-2024 | Current |
Financial Performance of Esteve Pharma.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Esteve Pharma?
Unlock access to Esteve Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹3.93 Cr
₹0.33 Cr
Charges Breakdown by Lending Institutions
- Canara Bank : 2.48 Cr
- Hdfc Bank Limited : 1.05 Cr
- Others : 0.41 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2024 | Hdfc Bank Limited | ₹1.22 M | Open |
| 18 Mar 2024 | Canara Bank | ₹0.60 M | Open |
| 19 Jan 2024 | Canara Bank | ₹0.75 M | Open |
| 30 Oct 2023 | Canara Bank | ₹3.70 M | Open |
| 11 Jul 2023 | Hdfc Bank Limited | ₹2.03 M | Open |
How Many Employees Work at Esteve Pharma?
Unlock and access historical data on people associated with Esteve Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Esteve Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Esteve Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
